Detection of anti-drug antibodies to aflibercept by enzyme-linked immunosorbent assay: Development and validation of the method

阿柏西普 抗体 色谱法 药品 化学 分子生物学 计算生物学 医学 药理学 生物 免疫学 内科学 化疗 贝伐单抗
作者
Ivan V. Shevchenko,A. E. Lisova,A. A. Agafonova,K. A. Smolova,I. M. Alaeva,I. Yu. Zhukov,A. A. Kazarov,Ivan V. Lyagoskin
出处
期刊:Биопрепараты. Профилактика, диагностика, лечение [SCEEMP]
卷期号:25 (3): 284-295
标识
DOI:10.30895/2221-996x-2025-631
摘要

INTRODUCTION. Aflibercept is used to treat neovascular age-related macular degeneration, a leading cause of vision loss. Immunogenicity is one of the significant adverse effects that results in the production of anti-drug antibodies (ADAs). The development of a method for detecting ADAs to aflibercept is essential for immunogenicity assessment. AIM. This study aimed to develop and validate an analytical method for detection and stepwise characterisation of total anti-drug antibodies to aflibercept in human serum utilising the enzyme-linked immunosorbent assay. MATERIALS AND METHODS. The method was developed using a solid-phase ELISA. Aflibercept (GNR-098, JSC GENERIUM, Russia) and a conjugate of GNR-098 with horseradish peroxidase were employed. Polyclonal antibodies against GNR-098 were obtained by immunising rats, followed by serum collection and antibody purification via affinity chromatography. ADA detection was performed using labelled GNR-098 in a bridging ELISA. Model samples were prepared by spiking pooled sera from healthy donors with rat polyclonal antibodies. Method validation included the following parameters: cut-off points; precision; limit of detection (LOD); drug tolerance; specificity; matrix effect; minimum required dilution; robustness; reagent stability; hook effect. RESULTS. An analytical method includes a screening assay for the presumptive detection of ADAs; a confirmatory assay to establish ADA specificity and assay for ADA titer determination and IgE isotyping. The cut-off points for the screening assay and IgE-specific assay were 1.3 and 1.2, respectively; for the confirmatory assay, 15.2%. The LOD of the screening assay was 185 ng/mL. The method demonstrated drug tolerance (interference from soluble target, hrVEGF165) at concentrations up to 2,000 pg/mL. No matrix effects were observed in the screening or confirmatory assays across 13 test samples containing ADAs at 280 ng/mL. The absence of a hook effect was confirmed in both assays using samples with ADA concentrations five times higher than the high-positive control. CONCLUSIONS. An analytical method was developed for the ELISA-based detection and stepwise characterisation of total anti-drug antibodies to aflibercept (GNR-098) in human serum. The method’s suitability was confirmed through validation. This analytical procedure will facilitate the immunogenicity assessment of aflibercept.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CodeCraft的应助被Rowling采纳,获得10
刚刚
刚刚
小药丸完成签到,获得积分10
刚刚
mkl发布了新的文献求助10
1秒前
一向光年有限身完成签到,获得积分10
1秒前
储召艳完成签到,获得积分10
1秒前
1秒前
2秒前
复杂的大树完成签到 ,获得积分10
2秒前
重要莹发布了新的文献求助10
2秒前
Liekkas完成签到,获得积分10
3秒前
活泼的芹菜完成签到,获得积分10
3秒前
Doctor完成签到,获得积分10
3秒前
MrHao发布了新的文献求助10
3秒前
4秒前
充电宝的应助被老帅比采纳,获得10
4秒前
哄哄完成签到,获得积分10
4秒前
碧蓝的迎梦完成签到,获得积分10
4秒前
迷人渊思完成签到,获得积分10
4秒前
wwwwww完成签到,获得积分10
4秒前
Spark完成签到,获得积分10
4秒前
5秒前
思源的应助被鲤鱼晟睿采纳,获得10
5秒前
半城完成签到,获得积分10
5秒前
6秒前
多情无敌完成签到,获得积分10
6秒前
7秒前
夜阑卧听完成签到,获得积分10
7秒前
7秒前
7秒前
内向问寒完成签到,获得积分10
8秒前
LGL完成签到,获得积分10
8秒前
ding的应助被顶刊相见采纳,获得10
8秒前
退后enid完成签到,获得积分10
9秒前
9秒前
9秒前
大个的应助被薛小飞采纳,获得10
9秒前
asdf完成签到,获得积分10
9秒前
9秒前
Lucky发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570485
关于积分的说明 21812623
捐赠科研通 7776592
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557522
邀请新用户注册赠送积分活动 2479162